Avanos Medical announced that Indrani Franchini, who most recently served as executive vice president and chief legal officer at Alnylam Pharmaceuticals, has been appointed as a new independent member of the Avanos board of directors.
From June 2017 to July 2021, she served as executive vice president and chief compliance officer at Alexion Pharmaceuticals. Prior to that, she held various roles in legal and compliance at Hess Corporation.
No comments yet